peterr.htm D 

Dr. Peter Rowe

Site currently under construction

Dr. Peter Rowe, Johns Hopkins University, Baltimore, Maryland

On-line References

Armstrong, G., Rowe, P. Orrbine, E., Lior, H., Goodyer, P., McLaine, P. and the CPKDRC SYNSORB-Pk Study Group. 1995. A phase 1 trial of SYNSORB-Pk in preventing hemolytic-uremic syndrome (HUS). ). J. Infect. Dis. 171:1042-1045

P.C. Rowe, E. Orrbine, H. Lior, G.A. Wells, and P.N. McLaine, A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. Epidemiol Infect 110:1-7(1993)

Should you have any further questions about the CPKDRC and its current projects, please contact Ms. Elaine Orrbine, Associate Director.